Article

wsj.comwsj.com on 2021-01-12 18:15

China’s Sinovac Covid-19 Vaccine Is 50.4% Effective in Late-Stage Brazil Trials

Results from Brazilian researchers testing China’s Sinovac Vaccine were almost 30 percentage points lower than previously announced, as concerns grow ...

Related news